Media release

LGT Private Debt provides debt facilities to support Ambienta’s acquisition of Agronova Biotech

LGT Private Debt has arranged debt facilities to support private equity investor Ambienta’s acquisition of Agronova Biotech, one of the leading global biological crop solutions platforms based in Spain. This marks LGT Private Debt’s third transaction in Spain in the last 14 months, following its investments in HT Médica and HTBA.

Pfaeffikon and Paris, 24 July 2025. Headquartered in Murcia, Spain, Agronova Biotech manufactures biological agricultural input products for crop nutrition and protection with a 50-year track record. The company services the full crop lifecycle, including nutrition, biofertilizers, biostimulants, and biocontrols. Agronova Biotech offers its extensive product portfolio in more than 50 countries across Europe and the Americas.

Kevin Abrial, Partner at LGT Private Debt, said: “We are pleased to partner with Ambienta again and look forward to supporting Agronova Biotech in its next phase of growth. We believe the company is well positioned to continue building its strong position in the biological agri-inputs market, driven by the accelerating shift to sustainable agricultural practices.”

Private debt is one of LGT Capital Partners’ areas of expertise in the field of private markets. The team has an average of 13 years of industry experience and is based in Paris, London and Frankfurt am Main. It has invested more than EUR 6.0 billion since 2005. As a specialist in the European private debt market, it arranged the first unitranche transaction in Europe in 2007. LGT Private Debt has been investing in Spain since 2015.

LGT Capital Partners

LGT Capital Partners is a leading global specialist in alternative investing with over USD 100 billion in assets under management and more than 700 institutional clients in 50 countries. An international team of over 900 professionals is responsible for managing a wide range of investment programs focusing on private markets, multi-alternatives and diversifying strategies, as well as sustainable and impact strategies. Headquartered in Pfaeffikon (SZ), Switzerland, the firm has offices in San Francisco, New York, Dublin, London, Paris, The Hague, Luxembourg, Frankfurt am Main, Vaduz, Dubai, Beijing, Hong Kong, Tokyo, Singapore and Sydney.

Kistner_Sebastian

Sebastian Kistner

Head of Corporate Communications

IMPORTANT INFORMATION

AuM is estimated and subject to change. Private market assets are stated in terms of committed capital. This marketing material was issued by LGT Capital Partners Ltd., Schuetzenstrasse 6, CH-8808 Pfaeffikon, Switzerland and/or its affiliates (hereafter "LGT CP") with the greatest of care and to the best of its knowledge and belief. LGT CP provides no guarantee with regard to its content and completeness and does not accept any liability for losses which might arise from making use of this information. The opinions expressed in this marketing material are those of LGT CP at the time of writing and are subject to change at any time without notice. If nothing is indicated to the contrary, all figures are unaudited. This marketing material is provided for information purposes only and is for the exclusive use of the recipient. It does not constitute an offer or a recommendation to buy or sell financial instruments or services and does not release the recipient from exercising his/her own judgment. This marketing material may not be reproduced either in part or in full without the written permission of LGT CP. It is not intended for persons who, due to their nationality, place of residence, or any other reason are not permitted access to such information under local law.

lgt_private_debt_provides_debt_facilities_to_support_ambientas_acquisition_of_agronova_biotech.pdf

pdf99.86 KB
Download